Relationships between Platelets and Blood Cells in Postprandial Glycemia in Healthy Individuals

2004 ◽  
Vol 30 (3) ◽  
pp. 349-352
Author(s):  
S. A. Pavlishchuk ◽  
G. G. Petrik ◽  
L. F. Nikol'skaya
Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 1262-1262
Author(s):  
Katarzyna Bogunia-Kubik ◽  
Anna Kuzyk ◽  
Emilia Jaskula ◽  
Andrzej Lange

Abstract Epstein-Barr virus (EBV) reactivation is a serious complication affecting the recipients of allogeneic hematopoietic stem cell transplants (HSCT). Chemokines and their receptors play a major role in the inflammatory and immune responses that mediate allograft outcome. CC-chemokine receptor-5 (CCR5) is known to be involved in perpetuation of HIV infection (as a co-receptor for HIV entry) and the clinical course of this infection is favored by the presence of the 32-nucleotide deletion within the CCR5 gene (CCR5Δ32 polymorphism). The CCR5 deletion mutation (CCR5Δ32) results in a non-functional chemokine receptor. In the present study the CCR5Δ32 polymorphism and two single nucleotide substitutions (−28 C/G; −403 G/A) within, one of the CCR5 ligands, the CCL5/RANTES gene were analyzed in 75 HSCT recipients, 75 donors and related with EBV load. The control group constituted 99 healthy individuals. DNA was extracted from peripheral blood taken into EDTA using silica membranes. Viral load were assessed 2-3 moths after transplantation in blood cells employing a real-time PCR technique. The detection threshold for viral reactivation equaled 10 EBV-DNA copies/105 peripheral blood cells. EBV reactivation was detected in 26 patients. The CCR5Δ32 and RANTES (−28 C/G; −403 G/A) polymorphisms were analyzed by PCR and PCR-RFLP technique, respectively. Distributions of CCR5 and RANTES −28 genotypes were similar in patients, donors and healthy individuals. RANTES −403 AA homozygosity was more frequent in donors than controls (0.61 vs 0.47, p=0.036). The higher number of EBV copies was detected in patients lacking CCR5Δ32 deletion (0.92 vs 0.71, p=0.031). No significant correlation between EBV reactivation and RANTES −28 C/G polymorphism. However, patients transplanted with donors homozygous for RANTES −403 AA (genotype associated with an increased expression of the RANTES gene) more frequently presented with EBV reactivation (0.85 vs 0.49, p=0.002). In conclusion, the presence of the CCR5 deletion-mutation in the recipient and RANTES-403 G in the donor of HSC appeared to lower the susceptibility for EBV reactivation.


Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 976-976
Author(s):  
Hiroyuki Takamatsu ◽  
Xingmin Feng ◽  
Xuzhang Lu ◽  
Tatsuya Chuhjo ◽  
Katsuya Okawa ◽  
...  

Abstract Although aplastic anemia (AA) is a T-cell mediated disease, recent studies have revealed the presence of antibodies (Abs) specific to proteins derived from hematopoietic progenitor cells in the serum of AA patients. It is as yet unclear whether these auto-Abs play some roles in the pathophysiology of AA. We previously demonstrated that Abs specific to moesin, a membrane-cytoskeleton linker protein in the cytoplasm, were detectable in approximately 37% of AA patients. Some reports identified moesin-like molecules on the surface of blood cells such as T cells and macrophages. It is therefore conceivable that anti-moesin Ab in AA patients may bind these immune cells and modulate hematopoietic function of AA patients. To test these hypotheses, we first studied the expression of moesin on various types of blood cells using monoclonal Ab specific to moesin (clone 38/87). Flow cytometry detected the expression of the protein recognized by anti-moesin Ab on T cells and monocytes from healthy individuals, acute monocytic leukemia cells lines including U937 and THP-1, and an acute T-lymphoblastic leukemia cell line, Molt-4, but failed to detect the molecule on CD34+ cells from healthy individuals and myeloid leukemia cell lines as well as B-lymphoblastic leukemia cell lines. Treatment of THP-1 cells with phorbol 12-myristate 13-acetate (PMA)/lipopolysaccharide (LPS) augmented the expression level of moesin. To confirm the expression of the moesin-like protein on the surface of monocytic leukemia cell lines, Molt-4 and THP-1 were treated with sulfo-NHS-SS-biotin, and the cell surface proteins were isolated with avidin-fixed column, and were subjected to Western blotting and peptide mass fingerprinting. Western blotting with anti-moesin monoclonal Abs showed two clear bands of proteins (75 kD and 80 kD); an amino acid sequence compatible with moesin was confirmed in the protein eluted from the 80 kD band. Next, we purified anti-moesin Abs from AA patients’ sera using affinity chromatography with recombinant moesin protein. Western blotting showed binding of the serum-derived Abs to a fraction of surface proteins of Molt-4, U937 and THP-1. When THP-1 cells were incubated in the presence of PMA and LPS with 5 αg/ml of control IgG or anti-moesin Abs derived from an AA patient’s serum, TNF-α production from THP-1 cells stimulated by anti-moesin Abs was 1.9–2.3 times as much as that from the control culture depending on the concentration of LPS. Incubation of THP-1 cells in the presence of monoclonal anti-moesin Abs showed the similar augmentation of TNF-α production. These results indicate that anti-moesin Abs may be involved in the suppression of hematopoiesis of AA patients by stimulating TNF-α production from monocytes.


2021 ◽  
Vol 15 (7) ◽  
pp. 1966-1968
Author(s):  
Mahdi Shahriari ◽  
Mohammad Azadbakht ◽  
Maryam Roohparvar ◽  
Babak Daneshfard ◽  
Majid Nimrouzi

Neutropenia is a common complication of chemotherapy in leukemic patients. An herbal formulation of chamomile was hypothesized to be effective on neutropenia. A group of healthy volunteers and two groups of patients received chamomile oral drop to be compared with a control group of neutropenic patients. Results showed an increase of white blood cells and resolution of neutropenia in all groups except for the control group. In conclusion, chamomile could be used as an effective complementary medicine for increasing the immunity of neutropenic patients (in addition to healthy individuals). Keywords: Chamomile; Leukemia; Chemotherapy; Neutropenia; Integrative Medicine; Persian Medicine


Author(s):  
Mirthes Ueda ◽  
Adelaide José Vaz ◽  
Eide Dias Camargo ◽  
Ana Maria Carvalho de Souza ◽  
Regina Maria Figueiredo Benelli ◽  
...  

A comparison of two different standardized reagent procedures for the passive haemagglutination test (PHA) in the detection of specific antibody to Cysticercus cellulosae in cerebrospinal fluid (CSF) was carried out. The formaldehyde-treated group O Rh-human red blood cells (HuRBC) and glutaraldehyde-treated sheep red blood cells (SRBC) were the supplies for the reagents preparation and, in the tests, they were designated as PHA-1 and PHA-2, respectively. For both reagents the cells were coated with the cysticerci total saline extract (TS) antigen. PHA-1 and PHA-2 were assessed in a total of 204 CSF from patients with neurocysticercosis, from non-related infections and from healthy individuals. The positivity and specificity indices obtained were respectively 81.7% and 94.4% for PHA-1 and for PHA-2, 88.7% and 96.6%. Since no significant differences were observed between the results provided by two reagents, at level of significance of 0.05, either processes of cell sensitization can alternatively be used according to the own laboratory convenience.


2019 ◽  
Vol 158 (2) ◽  
pp. 56-62 ◽  
Author(s):  
Kenichiro Ogushi ◽  
Atsushi Hattori ◽  
Erina Suzuki ◽  
Hirohito Shima ◽  
Masako Izawa ◽  
...  

SHOX resides in the short arm pseudoautosomal region (PAR1) of the sex chromosomes and escapes X inactivation. SHOX haploinsufficiency underlies idiopathic short stature (ISS) and Leri-Weill dyschondrosteosis (LWD). A substantial percentage of cases with SHOX haploinsufficiency arise from pseudoautosomal copy number variations (CNVs) involving putative enhancer regions of SHOX. Our previous study using peripheral blood samples showed that some CpG dinucleotides adjacent to SHOX exon 1 were hypomethylated in a healthy woman and methylated in a woman with gross X chromosomal rearrangements. However, it remains unknown whether submicroscopic pseudoautosomal CNVs cause aberrant DNA methylation of SHOX-flanking CpG islands. In this study, we examined the DNA methylation status of SHOX-flanking CpG islands in 50 healthy individuals and 10 ISS/LWD patients with pseudoautosomal CNVs. In silico analysis detected 3 CpG islands within the 20-kb region from the translation start site of SHOX. Pyrosequencing and bisulfite sequencing of genomic DNA samples revealed that these CpG islands were barely methylated in peripheral blood cells and cultured chondrocytes of healthy individuals, as well as in peripheral blood cells of ISS/LWD patients with pseudoautosomal CNVs. These results, in conjunction with our previous findings, indicate that the DNA methylation status of SHOX-flanking CpG islands can be affected by gross X-chromosomal abnormalities, but not by submicroscopic CNVs in PAR1. Such CNVs likely disturb SHOX expression through DNA methylation-independent mechanisms, which need to be determined in future studies.


2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Alessio Bellini ◽  
Andrea Nicolò ◽  
Ilenia Bazzucchi ◽  
Massimo Sacchetti

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 2232-2232 ◽  
Author(s):  
Mohammad Khan ◽  
Takashi Hattori ◽  
Stefan Niewiarowski ◽  
L. Henry Edmunds ◽  
Robert W. Colman

Abstract Soluble plasma tissue factor (TF) circulates in picomolar concentrations in healthy individuals and increases in a wide spectrum of diseases. This study tests the hypothesis that both truncated or long length TF antigens in low concentrations combine with monocytes or platelets to convert factor VII (fVII) to fVIIa. Both recombinant truncated TF (rsTF, kDa 33) and long length (47 kDa) plasma TF (pTF), obtained from pericardial wounds of patients having cardiac surgery using cardiopulmonary bypass, were studied in association with blood cells and TF bearing microparticles. Tissue factor was measured by ELISA. RsTF binds to erythrocytes, platelets, mononuclear cells and neutrophils. The rate of fVII conversion with rsTF (1.0 – 103nmoles/L) is fastest with mononuclear cells, less with platelets, minimal with neutrophils and undetectable with erythrocytes. Both unstimulated and stimulated mononuclear cells or platelets in the presence of 3.5 pmoles/L rsTF or pTF convert fVII (10 nmoles/L) to fVIIa, but the amounts of fVIIa produced is greater in mononuclear cells. When leukocytes or platelets are absent, microparticles associated with 3.5 pmoles/L TF antigen, derived from pericardial wound plasma, do not activate fVII. Stimulated mononuclear cells convert nearly all available fVII (10 nmoles/L) to fVIIa with 3.5 pmoles/L pTF. Unstimulated mononuclear cells convert small amounts of fVII with as little as 1 pmole/L rsTF but no VIIa is produced by platelets, neutrophils or erythrocytes under these conditions. At all concentrations (0.001 to 1m moles/L) mononuclear cells more efficiently convert fVII to fVIIa than platelets. This study shows that stimulated mononuclear cells provide the most efficient phospholipid platform for activation of truncated or long length molecules of soluble TF at low concentrations of TF antigen. The results suggest a new mechanism by which soluble TF, which is increased in clinical inflammatory diseases, may lead to a prothrombotic state.


Blood ◽  
2015 ◽  
Vol 126 (23) ◽  
pp. 4540-4540 ◽  
Author(s):  
Mashrafi Ahmed ◽  
Ashok R. Patel

Abstract Introduction: Schistocytes are split red blood cells that indicate microangiopathic hemolytic anemia. Their presence in a peripheral smear is the hallmark for diagnosing thrombotic thrombocytopenic purpura (TTP). Schistocytes may also be seen in healthy individuals and in patients with other diseases such as preeclampsia, eclampsia, chronic renal failure, solid organ or bone marrow transplantation, and diabetic microangiopathy as well as in patients with a prosthetic heart valve. Burr cells (echinocytes) are red blood cells with short, evenly spaced spicules and preserved central pallor that is usually artifactual (observed in uremia and liver disease). There has been no clear definition of a reference range for schistocytes or burr cells in normal individuals and among patients with various diseases. A previous study by Burns et al. included only 40 normal individuals to analyze the presence of schistocytes. In this study, we analyzed peripheral smears of 148 normal individuals to detect the normal reference range of schistocytes and burr cells in healthy adults and also attempted to determine the number of RBCs that need to be evaluated to consider the evaluation satisfactory. Method: We evaluated 148 peripheral blood smears of blood samples obtained from apparently healthy ambulatory adults (>18 years of age) with normal hemoglobin to determine the presence of schistocytes and burr cells. Result: Schistocytes were observed in approximately 78% of normal individuals with a mean of 0.15% of all RBCs. This finding is different from that of a previous study by Burns et al. (3) where schistocytes were observed in 58% of normal individual. Burr cell were observed in 77% of normal individual with a mean of 0.051% of all RBCs. Table 1. Analysis of collected data for schistocytes RBC Count Mean Std. Deviation 95% CI (predicted values) 1000 1.73 1.26 1.51-1.93 2000 1.92 1.56 1.74-2.14 3000 1.59 1.26 1.39-1.80 4000 1.17 0.97 0.97-1.37 5000 1.26 1.10 1.06-1.46 Total 1.54 1.28 Table 2. Analysis of collected data for burr cells RBC Count Mean Std. Deviation 95% CI (predicted values) 1000 0.86 0.87 0.75-0.98 2000 0.34 0.50 0.23-0.45 3000 0.59 0.79 0.48-0.70 4000 0.32 0.69 0.20-0.43 5000 0.44 0.56 0.33-0.553 Total 0.51 0.72 Discussion: TTP is an acute hematologic disorder involving different organ systems. The main pathophysiology of the disease is microvascular thrombosis due to increased platelet aggregation resulting in mechanical damage to erythrocytes. The diagnosis of TTP is predominantly based on characteristic clinical and laboratory findings. Therefore, observing schistocytes on peripheral smear is one of the key findings in the diagnostic process. A schistocyte is a fragmented erythrocyte characteristic of hemolysis or cell fragmentation. There is no clear definition of its appearance, shape, or size. Schistocyte recognition in the peripheral smear is largely based on clinician experience. Its mere presence is not exclusive of any pathological conditions only because it can also be observed in peripheral smears of a healthy patient. In the study by Burns et al., schistocytes were found in all patients with a mechanical heart valve, in 93% of patients with chronic renal failure, and in 58% of normal individuals. This finding is significantly different from that of our study where schistocytes were present in 87% of normal individuals. The reason of such a difference may be the extensive evaluation of each peripheral smear with the analysis of at least 5000 cells on each slide. Burr cells, also known as echinocytes, have a speculated border over the entire cell surface. Burr cells are commonly found in both end-stage renal disease and liver disease. In our study, Burr cells were found in 80% of healthy individuals although the numbers of cells are very small. One of the key findings in our analysis is determining the successful evaluation of peripheral smears for these two morphological variants of RBCs. Our data show that there is no significant change in the variation of the presence of schistocytes if 3000 erythrocytes are evaluated in a peripheral smear. For Burr cells, the analysis of 1000 erythrocytes in a high-power field appears sufficient. However, the drawback is that it is extremely time consuming to manually count such high numbers of RBCs and thus, the chance of an error is quite high. Disclosures No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document